Japan Updates Blueprint for Preparing for GMP Inspections

Drug Industry Daily
A A
Japan’s national drug regulator has asked drugmakers to submit information on stability monitoring and water purity, in addition to existing requirements, when they apply for mandatory post-approval GMP inspections.

To View This Article:

Login

Subscribe To Drug Industry Daily